Clinical Trials Logo

Heart Diseases clinical trials

View clinical trials related to Heart Diseases.

Filter by:

NCT ID: NCT02499731 Completed - Obesity Clinical Trials

Strong Hearts: Rural CVD Prevention

Start date: March 2014
Phase: N/A
Study type: Interventional

Strong Hearts, Healthy Communities is a research study which aims to reduce cardiovascular disease (CVD), improve quality of life, and reduce CVD related health care costs in rural communities. The investigators' aim is to better understand how changes in lifestyle can affect the health of rural women and others in their communities.

NCT ID: NCT02492269 Active, not recruiting - Clinical trials for Congenital Heart Disease

Stress Response and Neurodevelopmental Outcome After Cardiac Surgery Utilizing CPB in Children: A Prospective, Double Blinded and Randomized Study

Start date: May 2014
Phase: Phase 2
Study type: Interventional

The overall goal of this project is to determine the role of anesthetic management in children undergoing cardiac surgery utilizing CPB in the setting of fast tracking and early extubation. An ideal anesthetic technique would ensure abolishing or diminishing stress response as would be evident by the stress markers levels and the level of two cerebral injury biomarkers (S 100 B and NSE). This should translate to better immediate postoperative outcome and hopefully improve both the short and the long term neurodevelopmental outcome in these children. The project is prospective, randomized and blinded study. The first and second aim of the study should be conducted over 2 year period. Our long term aim will be concluded when these children reach the school age.

NCT ID: NCT02491931 Completed - Clinical trials for Ischemic Heart Disease

Oral Glutamine in Cardiopulmonary Bypass

Start date: January 2013
Phase: N/A
Study type: Interventional

Introduction: Glutamine (GLN) is the most abundant free amino acid in the body. It modulates immune cell function and is an important energy substrate for most cells (especially for enterocytes and lymphocytes) in critical patients. GLN levels significantly decreased during sepsis/critical illness leading to an increase in infectious complications, organ failure and mortality. Moreover, in cases of ischemia/reperfusion injury in the myocardium, GLN increases the levels of Adenosine triphosphate (ATP)/Adenosine diphosphate (ADP) ratio and prevents intracellular lactate accumulation. Recently, the perioperative effect of intravenous and oral GLN treatment been associated in lowering levels of cardiac injury markers such as Troponin-I (TROP-I) and the number of postoperative complications in patients who underwent Cardiopulmonary Bypass (CPB). The aim of the study was to analyze the oral dose of preoperative oral GLN treatment in patients who underwent CPB with extracorporeal circulation in Mexican patients.

NCT ID: NCT02490644 Completed - Clinical trials for Valvular Heart Disease

Role of High Mobility Group Box 1 as a Prognostic Biomarker in Patients Undergoing Valvular Heart Surgery

Start date: January 12, 2015
Phase:
Study type: Observational

One of the most important factor that affects the post op complication of the cardiac surgery is systemic inflammation. Valvular heart surgery requires cardiopulmonary bypass and cardioplegic arrest, which can arouse the ischemic/reperfusion injury causing myocardial damage and inflammatory response. These myocardial damage and inflammatory response can cause multi-organ failure or even death.

NCT ID: NCT02488876 Recruiting - Heart Diseases Clinical Trials

Database of Tissue Samples to Understand the Inflammatory Response After Cardiac Surgery

Start date: April 2009
Phase: N/A
Study type: Observational [Patient Registry]

The aim of this study is to collect non-individual related blood samples for the compelling of a unique database of tissue samples to understand the inflammatory responds after cardiac surgery on an on-going basis. This includes especially protein analyses and genetic testing for certain neurotransmitters in the blood and tissues to understand disease markers related to heart disease. The study is designed as an openly recruiting biobank with the purpose to later serve multiple study purposes. Outcomes refer to protein analyses and genetic testing for neurotransmitters in the blood and tissues.

NCT ID: NCT02484157 Completed - Cardiac Disease Clinical Trials

Comparison of ACT Between Hemochron Jr and ACT Plus

Start date: December 2012
Phase: N/A
Study type: Interventional

This study aimed to compare 2 activated clotting time analysers (Hemochron Jr vs. ACT Plus).

NCT ID: NCT02484144 Completed - Cardiac Disease Clinical Trials

Evaluation of the Information of the Patient Before a Scheduled Coronarography

INFOCORO
Start date: July 2015
Phase: N/A
Study type: Observational

French study, multicentrique with the cooperation of several hospital centers . 700 patients (200 in the stage 1 and 500 in the stage 2). Every patient will complete questionnaires in a anonymous way.

NCT ID: NCT02481791 Recruiting - Heart Diseases Clinical Trials

Study to Evaluate the Optimal Dose of Remifentanil During MRI of the Heart Under General Anaesthesia

Start date: July 2015
Phase: Phase 3
Study type: Interventional

What is the optimal maintenance dose of remifentanil to ensure apnoea, during breath hold episodes in children having cardiac MR imaging with general anaesthesia?

NCT ID: NCT02479581 Completed - Clinical trials for Valvular Heart Disease

The Safety and Efficacy of the Enhanced Recovery After Surgery(ERAS)Applied on Cardiac Surgery With Cardiopulmonary Bypass

ERAS
Start date: July 2015
Phase: Phase 2
Study type: Interventional

This study evaluates the enhanced recovery after surgery (ERAS) concept over conventional postoperative care in patients with heart valve disease undergoing cardiac surgery with cardiopulmonary bypass. Half of participants will adherence to the ERAS, while the other half will under the conventional postoperative care.

NCT ID: NCT02475759 Completed - Clinical trials for Congenital Heart Disease

Nutritional Prehabilitation Program and Cardiac Surgery Outcome in Pediatrics

Start date: November 1, 2017
Phase: N/A
Study type: Interventional

Nutritional Prehabilitation Program and Cardiac Surgery Outcome in Pediatrics. A randomized controlled trial.